TJ Biotech Holding ApS: Financial statements 2021
CVR: 41953616
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
TJ Biotech Holding ApS (CVR 41953616) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 1,749,111 and a net result of DKK 412,666 compared with DKK 90,196 the year before. That is an increase of 23.5% compared with the year before. Equity in the 2021 report amounted to DKK 23,484,130. The solvency ratio was 95.8%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 1,749,111
- Profit/Loss
- DKK 412,666
- Equity
- DKK 23,484,130
- Total Assets
- DKK 24,509,406
- Employees
- 1
Official annual report
Find more companies like TJ Biotech Holding ApS
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2021
TJ Biotech Holding ApS has published its annual report for 2020. Gross profit came to DKK 1,416,046, and the net result was DKK 90,196.
About TJ Biotech Holding ApS
TJ Biotech Holding ApS is a Danish company of the type Anpartsselskab based in Holte, founded in 2020. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The management consists of Thomas Engelbrecht Nordkild Jonassen. The company is owned by Thomas Engelbrecht Nordkild Jonassen. The company has 1 employee (2021). In 2025, the company reported a gross profit of DKK 70,424 and a net result of DKK 4,184,576 compared with DKK 667,738 the year before. Equity in the 2025 report amounted to DKK 18,607,145.
